Dengvaxia US Pregnancy Registry
Recruiting
Observational Study
Dengue Virus Infection
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Sanofi Pasteur, a Sanofi Company · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary objective of this study is to assess maternal, obstetrical, pregnancy, and neonatal and infant outcomes among women and their offspring(s) vaccinated with Dengvaxia during their pregnancy
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
The eligible population will include pregnant women of any age and their offspring(s) residing in the US and its Territories whose Dengvaxia pregnancy exposure is reported to the pregnancy registry.
Reports of Dengvaxia pregnancy exposure must contain the following information to be included in the…
Contacts
Dengvaxia US Pregnancy Registry HelpLine
1-800-822-2463
CONTACT
Trial Transparency email recommended (Toll free number for US & Canada)
800-633-1610
CONTACT